Publication: Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19)
Issued Date
2021-02-01
Resource Type
ISSN
13652710
02694727
02694727
Other identifier(s)
2-s2.0-85092899374
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Pharmacy and Therapeutics. Vol.46, No.1 (2021), 236-239
Suggested Citation
Bhitta Surapat, Somnuek Sungkanuparph, Suppachok Kirdlarp, Nantaporn Lekpittaya, Krittaya Chunnguleum Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19). Journal of Clinical Pharmacy and Therapeutics. Vol.46, No.1 (2021), 236-239. doi:10.1111/jcpt.13293 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78503
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19)
Other Contributor(s)
Abstract
What is known and objective: Clinical pharmacists actively participate in patient care via patients’ medication use. Yet the setting of Coronavirus Disease 2019 (COVID-19) limits patient contact with healthcare personnel. We aimed to review the services provided and drug-related problems detected using telemonitoring methods to guide clinical pharmacists in providing service in treating COVID-19 patients. Comment: At a tertiary care hospital in Thailand, clinical pharmacists provided pharmaceutical care services for COVID-19 patients via telemonitoring using the hospital's computerized physician order entry system. The pharmacists were able to provide therapeutic drug monitoring services, especially for anticoagulants. Many patients were considered special populations, with individualized requirements for drug dosing. Some adverse drug reactions were observed. Drug-related problems were mostly related to medication use in critically ill patients. What is new and conclusion: Telemonitoring is a viable method for clinical pharmacists to provide pharmaceutical care and meet the challenges posed by treating patients with COVID-19.